CERN-hosted Workshop on Design Characteristics of a Novel Linear Accelerator for Challenging Environments - Improving global access to radiation therapy

from Monday 7 November 2016 (08:00) to Tuesday 8 November 2016 (17:30)
CERN (31/3-004)

        : Sessions
    /     : Talks
        : Breaks
7 Nov 2016
8 Nov 2016
AM
08:00 --- Coffee and Registration ---
08:30 I. Welcome to CERN: Frederick Bordry - Frederick Bordry (CERN)   (31/3-004 - IT Amphitheatre)
08:35 II. Welcome and Goals of the Workshop: Norman Coleman, Manjit Dosanjh and David Pistenmaa - C. Norman Coleman (National Cancer Institute) Manjit Dosanjh David Pistenmaa   (31/3-004 - IT Amphitheatre)
08:45
III. Unique Partnerships to Improve Radiation Oncology in Low- and Middle-Income Countries: Moderator: Manjit Dosanjh (until 09:50) (31/3-004 - IT Amphitheatre)
08:50 III. A. Summary of findings of the Global Task Force for Radiation Control Cancer (GTFRCC) - Mary Gospodarowicz   (31/3-004 - IT Amphitheatre)
09:05 III. B. Balancing Equity and Advancement in Radiotherapy: How Economics Can Help Solve Global Health Challenges - Danielle Rodin   (31/3-004 - IT Amphitheatre)
09:20 III. C. Cobalt-60 and Cancer Treatment: the NNSA Radiological Security Mission - Katherine Holt   (31/3-004 - IT Amphitheatre)
09:35 III. D. Treatment not Terror: Improving Cancer Treatment while Reducing Security Risks - Miles Pomper   (31/3-004 - IT Amphitheatre)
09:50 --- Coffee Break ---
10:20
IV. Lessons from Past and Current Radiation Therapy Initiatives: What Works or Does not Work in Low- and Middle-Income Countries, and Why: Moderator: Yakov Pipman (until 10:55) (31/3-004 - IT Amphitheatre)
10:25 IV. A. IAEA's perspective - Zubi Zubizarreta   (31/3-004 - IT Amphitheatre)
10:45 IV. B. Open Discussion   (31/3-004 - IT Amphitheatre)
10:55
V. Design Considerations for a Linear Accelerator for Challenging Environments - Moderator: Richard Lanza (until 11:40) (31/3-004 - IT Amphitheatre)
11:00 V. A. Radiation Oncology in Africa; Current State and Future Goals - Surbhi Grover   (31/3-004 - IT Amphitheatre)
11:15 V. B. Machine Parameters and Machine Operational Features to Satisfy Requirements - Ahmed Meghzifene   (31/3-004 - IT Amphitheatre)
11:35 V. C. “Dreamliner” Novel Linear Accelerator Features for Challenging Environments - David Pistenmaa (ICEC)   (31/3-004 - IT Amphitheatre)
11:40 VI. NASA’s Experience in the Modular Design of Complex Systems - Ron Cobbs   (31/3-004 - IT Amphitheatre)
08:00 --- Coffee and Registration ---
08:30
VIII. Summary of Design Characteristics for a Novel Linear Accelerator for Challenging Environments: Moderator: David Jaffray (until 09:50) (31/3-004 - IT Amphitheatre)
08:35 VIII. A. Recommendations emanating from Session VII - Alberto Degiovanni (CERN) Ugo Amaldi (TERA Foundation (IT))   (31/3-004 - IT Amphitheatre)
09:00 VIII. B. Open discussion   (31/3-004 - IT Amphitheatre)
09:50 --- Coffee Break ---
10:20
IX. What Will it Take to Make it Happen?: Moderator: Bruce Curran (until 11:25) (31/3-004 - IT Amphitheatre)
10:25 IX. A. How do we translate design characteristics into a working machine (From machine shop to the clinic)? - Jacques Bernier (GSMN)   (31/3-004 - IT Amphitheatre)
10:40 IX. B. Challenges in introducing new technology in the developing world - Andras Fehervary   (31/3-004 - IT Amphitheatre)
10:55 IX. C. Entrepreneurial strategies to make it happen - Ajit Singh   (31/3-004 - IT Amphitheatre)
11:10 IX. D. Determining the cost of new technologies such as the linear accelerator under consideration - Yolande Lievens   (31/3-004 - IT Amphitheatre)
11:25
X. Essential and Sustainable Infrastructure Needs in Challenging Environments: Moderator: Norman Coleman (until 12:00) (31/3-004 - IT Amphitheatre)
11:30 X. A. 1. Clinical considerations - C. Norman Coleman (National Cancer Institute)   (31/3-004 - IT Amphitheatre)
11:45 X. A. 2. Equipment and facility needs. - Ahmed Meghzifene   (31/3-004 - IT Amphitheatre)
PM
12:00 --- Lunch ---
13:00
VII. Options for Achieving a Novel Linear Accelerator for Challenging Environments; Exploiting advances in technology. (until 15:05) (31/3-004 - IT Amphitheatre)
13:00 VII. A. 1. Goals of Session VII - Alberto Degiovanni (CERN) Ugo Amaldi (TERA Foundation (IT))   (31/3-004 - IT Amphitheatre)
13:05 VII. A. 2. Experience gained from the GlobalDiagnostiX project - Romain Sahli   (31/3-004 - IT Amphitheatre)
13:22 VII. A. 3. Problems posed by "difficult" environments to present linac-based systems - John Allen   (31/3-004 - IT Amphitheatre)
13:39 VII. A. 4. Electron Linac Projects in Pakistan with CERN support - Sumaira Zeeshan   (31/3-004 - IT Amphitheatre)
13:56 VII. A. 5. IORT linac and possible developments - Luigi Picardi   (31/3-004 - IT Amphitheatre)
14:13 VII. A. 6. Experience on Electron Linacs at NCBJ (Poland) - Przemek Adrich   (31/3-004 - IT Amphitheatre)
14:30 VII. A. 7. Robust X-ray imaging - David Jaffray   (31/3-004 - IT Amphitheatre)
14:47 VII. A. 8. Lower cost RT through new software tools (optimization and automation) - Johan Lof   (31/3-004 - IT Amphitheatre)
15:05 --- Coffee break ---
15:30
VII. Options for Achieving a Novel Linear Accelerator for Challenging Environments; Exploiting advances in technology. (until 16:30) (31/3-004 - IT Amphitheatre)
15:30 VII. A. 9. Shielding in "difficult" environments - Pawel Krawczyk   (31/3-004 - IT Amphitheatre)
15:47 VII. A. 10. PHASER: Application of Advanced RF Linac Technology to Medical Accelerators - Billy Loo Sami Tantawi   (31/3-004 - IT Amphitheatre)
16:04 VII. A. 11. General Design Considerations on Structures, Power Sources and Accessories - Maurizio Vretenar   (31/3-004 - IT Amphitheatre)
16:21 VII. A. 12. Conclusions - Ugo Amaldi (TERA Foundation (IT))   (31/3-004 - IT Amphitheatre)
16:30
VII. Options for Achieving a Novel Linear Accelerator for Challenging Environments; Exploiting advances in technology. (until 17:00) (31/3-004 - IT Amphitheatre)
16:30 VII. B. Open discussion. Co-moderators: Ugo Amaldi, Alberto Degiovanni and David Pistenmaa   (31/3-004 - IT Amphitheatre)
19:00 --- Group Dinner: CERN VIP Restaurant ---
12:00 --- Lunch ---
13:00
X. Essential and Sustainable Infrastructure Needs in Challenging Environments: Moderator: Norman Coleman (until 13:20) (31/3-004 - IT Amphitheatre)
13:00 X. B. 1. Using modern technology to share medical knowledge worldwide - Zubi Zubizarreta   (31/3-004 - IT Amphitheatre)
13:20
X. Essential and Sustainable Infrastructure Needs in Challenging Environments: Moderator: Norman Coleman (until 14:30) (31/3-004 - IT Amphitheatre)
13:25 X. C. 1. Overview by the moderator - Yolande Lievens   (31/3-004 - IT Amphitheatre)
13:30 X. C. 2. Presentations by panel members: Norman Coleman, ICEC; Bruce Curran, AAPM; Nelly Enwerem-Bromson, IAEA; Patricia Hardenbergh, ASTRO; Ahmed Meghzifene, IAEA; Yakov Pipman, MPWB - Dr Yakov Pipman (MPWB) Patti Hardenbergh Bruce Curran C. Norman Coleman (National Cancer Institute) Ahmed Meghzifene Nelly Enwerem-Bromson   (31/3-004 - IT Amphitheatre)
14:00 X. C. 3. Open discussion   (31/3-004 - IT Amphitheatre)
14:30 --- Coffee break ---
15:00 XII. Concluding Remarks by Workshop Co-organizers - Manjit Dosanjh (CERN) David Pistenmaa (ICEC) C. Norman Coleman (National Cancer Institute)   (31/3-004 - IT Amphitheatre)
15:05
XI. Recommendations from the Workshop and Plans for the Future: Norman Coleman, Manjit Dosanjh and David Pistenmaa (until 15:50) (31/3-004 - IT Amphitheatre)
15:05 XI. A. 1. Design characteristics for a novel linear accelerator for challenging environments - Alberto Degiovanni (CERN)   (31/3-004 - IT Amphitheatre)
15:20 XI. A. 2. Achieving and sustaining the necessary infrastructure in challenging environments: Can we get by with less? - Bhadrasain Vikram   (31/3-004 - IT Amphitheatre)
15:35 XI. A. 3. Estimating the needs and planning for sustainable training of radiotherapy professional and ancillary staff in developing countries - Onyinye Balogun   (31/3-004 - IT Amphitheatre)
15:50 --- Coffee break ---
16:20
XI. Recommendations from the Workshop and Plans for the Future: Norman Coleman, Manjit Dosanjh and David Pistenmaa (until 16:30) (31/3-004 - IT Amphitheatre)
16:20 XI. B. Next steps - Manjit Dosanjh (CERN) David Pistenmaa (ICEC) C. Norman Coleman (National Cancer Institute)   (31/3-004 - IT Amphitheatre)